On Thursday, Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO), added 6.39% and closed at $12.15 in the last trading session. The last trading range of the stock ranges between $11.81 and $12.80. Halozyme Therapeutics, Inc. (HALO), an oncology biotech developing novel oncology and drug-delivery therapies, and Genentech, a member of the Roche Group, recently declared a contract to collaborate on clinical studies evaluating up to eight different tumor types starting in 2017.
The first study will be a Phase 1b/2 open-label, multi-arm randomized global study, led by Genentech to evaluate their cancer immunotherapy Tecentriq® (atezolizumab), an anti-PD-L1 monoclonal antibody, in combination with Halozyme’s investigational drug, PEGPH20 in six tumor types. Halozyme will supply drug only for the Genentech study. This study will have an initial focus on gastrointestinal malignancies, counting pancreatic and gastric cancers.
The second study will be a Phase 1b open-label randomized study led by Halozyme to assess Tecentriq in combination with PEGPH20 and chemotherapy in advanced or metastatic biliary and gallbladder cancers.
Juniper Networks, Inc. (NYSE:JNPR), dropped -0.36% and closed at $25.19 in the last trading session. The last trading range of the stock ranges between $24.97 and $25.82. The company’s Market capitalization is $9.57 Billion with the total Outstanding Shares of 380.32 million. Juniper Networks, Inc. designs, develops, and sells network products and services worldwide. It offers various routing products, counting ACX series universal access routers to deploy new high-bandwidth services; MX series Ethernet routers that functions as a universal edge platform; M series edge routers; PTX series packet transport routers; T series routers; and NorthStar controllers. The company also provides various switching products comprising EX series Ethernet switches to address the access, aggregation, and core layer switching requirements of micro branch, branch office, and campus and data center environments; QFX series of core, spine, and top-of-rack data center switches; and OCX1100, an open networking switch. In addition, it offers security products, such as SRX series services gateways for the data centers; Branch SRX family that includes SRX300 Series and SRX1500, which provides integrated firewall capabilities; vSRX Virtual Firewall that delivers various features of physical firewalls; Spotlight Secure Threat Intelligence Platform, a threat intelligence platform that aggregates threat feeds from various sources; and Sky Advanced Threat Prevention, a cloud-based service for static and dynamic analysis. Further, the company offers Junos OS, a network operating system; Junos Space, a network administration platform for creating network administration applications that include network director, services activation director, security director, edge services director, service now, and service insight; and Contrail networking and cloud platform solutions. In Addition To, it provides technical support and professional services, in addition to education and training programs.